Your feedback on video

Novartis clings to chairman

Feb 18 2013  Daniel Vasella, outgoing chairman of Novartis, has sparked controversy by agreeing to a SFr72m 'golden goodbye' from the Swiss pharmaceutical group. Mr Vasella will receive payments in exchange for not working for companies that compete with Novartis. Lex's Oliver Ralph and Vincent Boland discuss whether Mr Vasella did the right thing and what shareholders will make of the decision.  (3m 21sec)
Related Links:
Credits:
Produced by Nalini Sivathasan. Filmed by James MacDonald.

  • Editor's Choice
  • Next in section
  • Latest
  • Most popular

Companies

Markets

World

Global Economy

Management

Personal Finance

Life & Arts